NCT07343505

Brief Summary

This study aims to evaluate the effects of a structured environmental enrichment (EE)-based early developmental intervention on brain, motor, and cognitive outcomes in preterm infants. Infants born before 37 weeks of gestation are at increased risk for alterations in structural and functional brain development, which may be further influenced by the neonatal intensive care environment, including exposure to excessive light, noise, and frequent medical procedures. The intervention is a prospectively implemented, home-based developmental program structured according to the HEP (Homeostasis-Enrichment-Plasticity) approach, providing enriched sensory-motor experiences, environmental novelty, problem-solving activities, and opportunities for active exploration. The program is delivered through guided parental involvement with support from trained therapists, according to a predefined protocol. Developmental outcomes will be assessed at baseline and after the intervention period using standardized, non-invasive assessment tools. The intervention does not include any pharmacological treatment or medical device. This study evaluates whether participation in an EE-based early developmental intervention leads to improved neurodevelopmental outcomes in preterm infants.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
3mo left

Started Jan 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress58%
Jan 2026Jul 2026

First Submitted

Initial submission to the registry

November 21, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

January 15, 2026

Completed
Same day until next milestone

Study Start

First participant enrolled

January 15, 2026

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2026

Last Updated

January 15, 2026

Status Verified

January 1, 2026

Enrollment Period

6 months

First QC Date

November 21, 2025

Last Update Submit

January 6, 2026

Conditions

Keywords

Preterm infantsEnvironmental enrichmentHome-based interventionEarly interventionBrain developmentCognitive developmentMotor developmentNeurodevelopment

Outcome Measures

Primary Outcomes (2)

  • Motor Development Assessed by Bayley Scales of Infant and Toddler Development, Third Edition (Bayley-III)

    Motor development will be assessed using the Bayley Scales of Infant and Toddler Development, Third Edition (Bayley-III), Motor Composite Score, which evaluates fine and gross motor development. The Motor Composite Score ranges from 40 to 160, with higher scores indicating better motor development.

    Baseline (corrected age of 1 month) and 12 weeks (end of intervention)

  • Motor Performance Assessed by Test of Infant Motor Performance (TIMP)

    Motor performance will be assessed using the Test of Infant Motor Performance (TIMP), which evaluates postural and selective control of movement in young infants. The TIMP total score ranges from -49 to 142, with higher scores indicating better motor performance.

    Baseline (corrected age of 1 month) and 12 weeks (end of intervention)

Secondary Outcomes (7)

  • Cognitive Development Assessed by Bayley Scales of Infant and Toddler Development, Third Edition (Bayley-III)

    Baseline (corrected age of 1 month) and 12 weeks (end of intervention)

  • Brain Morphometric Measurements Assessed by Cranial Ultrasound Imaging

    Baseline (corrected age of 1 month) and 12 weeks (end of intervention)

  • Urinary Concentration of Brain-Derived Neurotrophic Factor (BDNF)

    Baseline (corrected age of 1 month) and 12 weeks (end of intervention)

  • Urinary Concentration of Nerve Growth Factor (NGF)

    Baseline (corrected age of 1 month) and 12 weeks (end of intervention)

  • Urinary Concentration of Tau Protein

    Baseline (corrected age of 1 month) and 12 weeks (end of intervention)

  • +2 more secondary outcomes

Study Arms (2)

Control Group

ACTIVE COMPARATOR

Infants in this group will receive conventional developmental therapy and routine medical follow-up as provided within standard clinical practice. This approach represents an active comparator and does not include the structured environmental enrichment or the Homeostasis-Enrichment-Plasticity (HEP)-based intervention used in the experimental group. Participants in this group will undergo the same study-related assessments as the intervention group at baseline and after 12 weeks.

Other: Standard Developmental Care

HEP Home-Practice Group:

EXPERIMENTAL

A structured environmental enrichment-based developmental intervention delivered over a 12-week period. The program is based on the Homeostasis-Enrichment-Plasticity (HEP) framework and includes age-appropriate sensory-motor activities, environmental novelty, problem-solving opportunities, and active caregiver-infant interaction. The intervention is delivered through weekly therapist-guided sessions, with caregivers encouraged to continue the practices at home as part of daily care.

Behavioral: Environmental Enrichment-Based Intervention

Interventions

Environmental enrichment-based program applied for 12 weeks, including sensory-motor stimulation, environmental novelty, problem-solving tasks, and active exploration with caregivers.

HEP Home-Practice Group:

Standard developmental care and routine medical follow-up provided within usual clinical practice. This care reflects established developmental support approaches typically offered to preterm infants and does not include structured environmental enrichment or the Homeostasis-Enrichment-Plasticity (HEP)-based intervention applied in the experimental group.

Control Group

Eligibility Criteria

Age4 Weeks - 7 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Preterm infants born before 37 completed weeks of gestation.
  • Corrected age between 4 and 7 weeks at the time of enrollment.
  • Medically stable, as confirmed by the attending neonatologist
  • Written informed consent obtained from parents or legal guardians.

You may not qualify if:

  • Major congenital anomalies or known genetic syndromes.
  • Severe intraventricular hemorrhage (Grade III-IV) or other major neurological impairment.
  • Unstable medical conditions that would interfere with safe participation in the study procedures.
  • Caregivers unable to attend scheduled study sessions or comply with study-related procedures.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tuğçe Altıok Physical Therapy Center

Nilufer, Bursa, 16110, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Tuğçe Altıok, PhD

    Eskisehir Osmangazi University, Institute of Health Sciences

    STUDY DIRECTOR
  • Ferruh Yücel, Professor, PhD

    Eskisehir Osmangazi University

    PRINCIPAL INVESTIGATOR
  • Aymen Balıkçı, PT, PhD

    Aymen Balıkçı Physical Therapy Clinic

    STUDY DIRECTOR
  • Teresa A. May-Benson, PhD

    Teresa A. May-Benson Therapy Clinic

    STUDY DIRECTOR

Central Study Contacts

Tuğçe Altıok, PhD / PT

CONTACT

Ferruh Yücel, Professor, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be prospectively assigned to one of two parallel groups using stratified assignment based on gestational age. One group will receive standard care alone, while the other group will receive a structured environmental enrichment-based HEP home intervention in addition to standard care.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD Candidate

Study Record Dates

First Submitted

November 21, 2025

First Posted

January 15, 2026

Study Start

January 15, 2026

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

July 30, 2026

Last Updated

January 15, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared.

Locations